DOV KADMON to Radiotherapy, Conformal
This is a "connection" page, showing publications DOV KADMON has written about Radiotherapy, Conformal.
Connection Strength
0.053
-
Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data. Int J Radiat Oncol Biol Phys. 2004 Apr 01; 58(5):1520-9.
Score: 0.053